1. Järvinen, T A H, Liu, E T. . Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated. In Cytopathology : official journal of the British Society for Clinical Cytology, 14, 309-13. doi:. https://pubmed.ncbi.nlm.nih.gov/14632727/
2. Cai, Hongyu, Zhu, Xinhua, Qian, Fei, Zhang, Yixin, Chen, Zhong. . High expression of TOP2A gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy. In Translational cancer research, 9, 983-992. doi:10.21037/tcr.2019.12.46. https://pubmed.ncbi.nlm.nih.gov/35117443/
3. Wang, Ke, Jiang, Xunliang, Jiang, Yu, Li, Jipeng, Zhang, Rui. 2023. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A. In Journal of experimental & clinical cancer research : CR, 42, 320. doi:10.1186/s13046-023-02855-2. https://pubmed.ncbi.nlm.nih.gov/38008711/
4. de Resende, Marina França, Vieira, Samantha, Chinen, Ludmilla Thomé Domingos, Brant, Xenia, Rocha, Rafael Malagoli. 2013. Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer. In Journal of translational medicine, 11, 36. doi:10.1186/1479-5876-11-36. https://pubmed.ncbi.nlm.nih.gov/23398928/
智鼠故事 
